Harrington Discovery Institute
Showing of 67 results
New Study Shows How to Protect the Brain to Prevent Depression and Cognitive Impairment Caused by Whole Brain Radiotherapy
Research team from University Hospitals, Case Western Reserve University and the Cleveland VA published results in Redox Biology.
Oxford-Harrington Rare Disease Centre Invites Proposals for 2026 Award
Prestigious Scholar Award Accelerates Novel Therapies for Patients with Rare Diseases.
Cleveland Researchers Discover Enzyme That Controls Both Weight Gain and Cholesterol Levels in Animal Models
New Study from University Hospitals and Case Western Reserve University published in Science Signaling.
New Study Shows Alzheimer’s Disease Can Be Reversed in Animal Models to Achieve Full Neurological Recovery, Not Just Prevented or Slowed
Researchers from University Hospitals, Case Western Reserve University and the Cleveland VA showed restoring the brain’s energy balance led to both pathological and functional recovery.
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases.
Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
Positive results of zalunfiban announced at AHA Scientific Sessions.
Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2026 Harrington-MSTP Scholar Award
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines.
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation.